Display Settings:

Format

Send to:

Choose Destination
    Crit Care. 2004 Aug;8(4):229-30. Epub 2004 Jun 9.

    N-acetylcysteine in clinical sepsis: a difficult marriage.

    Source

    Intensive Care Department, Academic Hospital, Vrije Universiteit Brussels, Belgium. herbert.spapen@az.vub.ac.be

    Abstract

    The high morbidity and mortality of severe sepsis and septic shock fosters a continuous search for novel therapies that go beyond pure correction of oxygenation and hemodynamics. Within this scope, N-acetylcysteine shows great promise. Beside proven anti-oxidant, anti-inflammatory and cytoprotective effects, N-acetylcysteine does also ensure endothelial protection and enhances microvascular blood flow. Studies that put these highly favourable properties to the clinical test remain scarce but are definitely needed to determine whether N-acetylcysteine has a place in our therapeutic armamentarium against sepsis.

    PMID:
    15312203
    [PubMed - indexed for MEDLINE]
    PMCID: PMC522849
    Free PMC Article

      Supplemental Content

      Click here to read

      Chemical compound information

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk